Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:18 PM
Ignite Modification Date:
2025-12-24 @ 5:18 PM
NCT ID:
NCT06247150
Eligibility Criteria:
Inclusion Criteria:
* Patient \> 18 yo ;
* Having undergone an allogeneic stem cell tranplant ;
* 2 groups of patients will be eligible
* showing evidence of primary cGVHD or occuring after Donor Lymphocyte Infusion
* in the case of first occurrence of cGVHD, in the absence of any new systemic therapy ;
* in the case of recurrent cGVHD, steroid dose has to be below 15mg/day of Prednisone ;
* Having read, understood and signed an informed consent of the study;
* With social security affiliation;
Exclusion Criteria:
* Patient below 18 yo or unable to give consent ;
* Systemic therapy using steroids over 15mg/d of Prednisone ; and/or the use of other systemic agent introduced in the last month ;
* Haemorrhagic risk of biopsy anticipated ;
* Absence of patient agreement for the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06247150
Study Brief:
Protocol Section:
NCT06247150